NDC 69448-026 – Udenyca
Pegfilgrastim 6 mg/.6mL · Injection, Solution · Subcutaneous
Product NDC69448-026
Product details
- Brand name
- Udenyca
- Generic name
- Pegfilgrastim-cbqv
- Labeler
- Accord BioPharma, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761039
- Marketed since
- March 23, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Leukocyte Growth Factor
Active ingredients
- Pegfilgrastim 6 mg/.6mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69448-026-63 | 1 SYRINGE in 1 CARTON (69448-026-63) / .6 mL in 1 SYRINGE | Mar 23, 2026 |
Recalls mentioning this NDC
- D-0353-2026 Feb 18, 2026 · Class I
Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
Other Udenyca products
- 69448-025 Pegfilgrastim 6 mg/.6mL · Injection, Solution · Accord BioPharma, Inc.
- 69448-027 Pegfilgrastim 6 mg/.6mL · Injection, Solution · Accord BioPharma, Inc.
- 70114-101 Pegfilgrastim 6 mg/.6mL · Injection, Solution · Coherus Oncology, Inc.
- 70114-120 Pegfilgrastim 6 mg/.6mL · Injection, Solution · Coherus Oncology, Inc.
- 70114-130 Pegfilgrastim 6 mg/.6mL · Injection, Solution · Coherus Oncology, Inc.